Imprimis Pharma (IMMY)

5.43 +0.49 (9.92%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (8/9/18 *Est.)

Latest Headlines

Lake Street Capital Markets Starts Imprimis Pharmaceuticals (IMMy) at Buy December 10, 2018 9:16 AM - StreetInsider Form 4 Imprimis Pharmaceuticals For: Dec 03 Filed by: Kammer Robert J December 6, 2018 6:11 AM - SEC Filing Imprimis Pharmaceuticals Ranked 88th Fastest Growing Company in North America on Deloitte’s 2018 Technology Fast 500™ November 16, 2018 7:30 AM - Globe NewsWire Pre-Open Movers 11/14: (CLD) (PETQ) (AMRN) Higher; (AMRS) (PCG) (MCD) Lower (more...) November 14, 2018 9:22 AM - StreetInsider After-Hours Movers 11/13: (IMMY) (CLD) (PETQ) Higher; (WIX) (APRN) (CDNA) Lower (more...) November 13, 2018 5:25 PM - StreetInsider Form 8-K Imprimis Pharmaceuticals For: Nov 13 November 13, 2018 4:23 PM - SEC Filing Form 10-Q Imprimis Pharmaceuticals For: Sep 30 November 13, 2018 4:21 PM - SEC Filing Imprimis Pharmaceuticals Announces Third Quarter 2018 Results November 13, 2018 4:01 PM - Globe NewsWire Form 8-K Imprimis Pharmaceuticals For: Nov 12 November 13, 2018 12:02 PM - SEC Filing Form 8-K Imprimis Pharmaceuticals For: Nov 05 November 6, 2018 7:15 AM - SEC Filing Imprimis Pharmaceuticals to Announce Third Quarter 2018 Financial Results on November 13, 2018 November 6, 2018 7:00 AM - Globe NewsWire Form 4 Imprimis Pharmaceuticals For: Nov 01 Filed by: Kammer Robert J November 2, 2018 6:21 PM - SEC Filing Form 8-K Imprimis Pharmaceuticals For: Oct 29 October 29, 2018 6:12 AM - SEC Filing Imprimis Pharma (IMMY) Subsidiary Melt Pharmaceuticals Commences Clinical Development Program for Patented Non-Opioid & Non-Invasive MK Melt Conscious Sedation Drug Candidate October 23, 2018 7:08 AM - StreetInsider Imprimis Pharmaceuticals’ Subsidiary Melt Pharmaceuticals Initiates Clinical Development Program for its Patented Non-Opioid and Non-Invasive MK Melt™ Conscious Sedation Drug Candidate October 23, 2018 7:00 AM - Globe NewsWire Form 4 Imprimis Pharmaceuticals For: Oct 15 Filed by: Kammer Robert J October 18, 2018 9:10 AM - SEC Filing ImprimisRx to feature new formulation and poster presentation on MKO Melt® at the upcoming American Academy of Ophthalmology Meeting in Chicago October 16, 2018 7:00 AM - Globe NewsWire Full Article List